Cell Signaling Technology

Cell Signaling Technology (CST), founded in 1999 and headquartered in Danvers, Massachusetts, is a prominent life sciences company dedicated to empowering scientific discovery. The company specializes in providing researchers with high-quality products and services essential for studying cell signaling pathways, which are critical to understanding human health and disease mechanisms. CST's comprehensive portfolio includes a wide array of antibodies, ELISA kits, ChIP kits, proteomic kits, and other specialized reagents. These tools are instrumental in advancing research in areas such as cancer, personalized medicine, and fundamental biological processes. The company's commitment to scientific rigor is reflected in its award-winning products and extensive databases, supporting researchers globally.

With a significant operational footprint, Cell Signaling Technology employs between 500 and 1,000 individuals, contributing to its robust product development and customer support. The company's dedication to advancing scientific understanding is further exemplified by its team's expertise and collaborative approach. Meet Cell Signaling Technology's team to learn more about the professionals driving innovation in the life sciences sector. CST's strategic focus on quality and scientific integrity ensures that its offerings meet the highest standards required for cutting-edge biomedical research.

Operating within the competitive biotechnology and business services sectors, Cell Signaling Technology serves a global clientele. Its revenue stands at $126.8M, underscoring its substantial market presence. The company's products are vital for researchers investigating disease pathways and developing novel therapeutic strategies. By providing reliable and validated tools, CST plays a crucial role in accelerating the pace of scientific breakthroughs and contributing to advancements in diagnostics and treatments.